BDULF
Price
$0.63
Change
+$0.01 (+1.61%)
Updated
Sep 3 closing price
Capitalization
10.34B
GBCS
Price
$2.35
Change
+$0.05 (+2.17%)
Updated
Sep 4 closing price
Capitalization
7.21M
Interact to see
Advertisement

BDULF vs GBCS

Header iconBDULF vs GBCS Comparison
Open Charts BDULF vs GBCSBanner chart's image
Bangkok Dusit Medical Services Public
Price$0.63
Change+$0.01 (+1.61%)
Volume$155
Capitalization10.34B
Selectis Health
Price$2.35
Change+$0.05 (+2.17%)
Volume$1.22K
Capitalization7.21M
BDULF vs GBCS Comparison Chart in %
Loading...
BDULF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDULF vs. GBCS commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDULF is a Hold and GBCS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (BDULF: $0.63 vs. GBCS: $2.35)
Brand notoriety: BDULF and GBCS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: BDULF: 7% vs. GBCS: 20%
Market capitalization -- BDULF: $10.34B vs. GBCS: $7.21M
BDULF [@Hospital/Nursing Management] is valued at $10.34B. GBCS’s [@Hospital/Nursing Management] market capitalization is $7.21M. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $98.46B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDULF’s FA Score shows that 1 FA rating(s) are green whileGBCS’s FA Score has 1 green FA rating(s).

  • BDULF’s FA Score: 1 green, 4 red.
  • GBCS’s FA Score: 1 green, 4 red.
According to our system of comparison, GBCS is a better buy in the long-term than BDULF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDULF’s TA Score shows that 3 TA indicator(s) are bullish while GBCS’s TA Score has 1 bullish TA indicator(s).

  • BDULF’s TA Score: 3 bullish, 2 bearish.
  • GBCS’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, BDULF is a better buy in the short-term than GBCS.

Price Growth

BDULF (@Hospital/Nursing Management) experienced а +1.69% price change this week, while GBCS (@Hospital/Nursing Management) price change was -2.89% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.56%. For the same industry, the average monthly price growth was +4.30%, and the average quarterly price growth was +7.17%.

Industries' Descriptions

@Hospital/Nursing Management (-0.56% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDULF($10.3B) has a higher market cap than GBCS($7.21M). GBCS YTD gains are higher at: 109.821 vs. BDULF (-25.767). BDULF has higher annual earnings (EBITDA): 27.7B vs. GBCS (-85.47K). BDULF has more cash in the bank: 6.74B vs. GBCS (560K). GBCS has less debt than BDULF: GBCS (31.6M) vs BDULF (16.4B). BDULF has higher revenues than GBCS: BDULF (110B) vs GBCS (41.3M).
BDULFGBCSBDULF / GBCS
Capitalization10.3B7.21M142,897%
EBITDA27.7B-85.47K-32,408,274%
Gain YTD-25.767109.821-23%
P/E Ratio19.81N/A-
Revenue110B41.3M266,344%
Total Cash6.74B560K1,202,679%
Total Debt16.4B31.6M51,899%
FUNDAMENTALS RATINGS
BDULF vs GBCS: Fundamental Ratings
BDULF
GBCS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
73
Overvalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
51100
PRICE GROWTH RATING
1..100
6244
P/E GROWTH RATING
1..100
8020
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BDULF's Valuation (10) in the null industry is somewhat better than the same rating for GBCS (73). This means that BDULF’s stock grew somewhat faster than GBCS’s over the last 12 months.

GBCS's Profit vs Risk Rating (94) in the null industry is in the same range as BDULF (100). This means that GBCS’s stock grew similarly to BDULF’s over the last 12 months.

BDULF's SMR Rating (51) in the null industry is somewhat better than the same rating for GBCS (100). This means that BDULF’s stock grew somewhat faster than GBCS’s over the last 12 months.

GBCS's Price Growth Rating (44) in the null industry is in the same range as BDULF (62). This means that GBCS’s stock grew similarly to BDULF’s over the last 12 months.

GBCS's P/E Growth Rating (20) in the null industry is somewhat better than the same rating for BDULF (80). This means that GBCS’s stock grew somewhat faster than BDULF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BDULFGBCS
RSI
ODDS (%)
Bearish Trend 3 days ago
22%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
14%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
20%
Bullish Trend 3 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
13%
Bearish Trend 3 days ago
73%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
50%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BDULF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBCS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SXTC1.610.23
+16.67%
China SXT Pharmaceuticals Inc.
DNTH26.501.84
+7.46%
Dianthus Therapeutics
ONC341.8023.07
+7.24%
BeOne Medicines Ltd
GDHG7.51-0.29
-3.72%
Golden Heaven Group Holdings Ltd
CRC49.03-2.52
-4.89%
California Resources Corp

BDULF and

Correlation & Price change

A.I.dvisor tells us that BDULF and MD have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDULF and MD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDULF
1D Price
Change %
BDULF100%
N/A
MD - BDULF
8%
Poorly correlated
+0.35%
PIII - BDULF
8%
Poorly correlated
+0.12%
NUMIF - BDULF
7%
Poorly correlated
-1.33%
RHEP - BDULF
6%
Poorly correlated
+0.11%
INNV - BDULF
5%
Poorly correlated
+3.84%
More

GBCS and

Correlation & Price change

A.I.dvisor tells us that GBCS and PIII have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GBCS and PIII's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBCS
1D Price
Change %
GBCS100%
N/A
PIII - GBCS
10%
Poorly correlated
+0.12%
PHCI - GBCS
2%
Poorly correlated
-17.42%
AIRS - GBCS
2%
Poorly correlated
-0.34%
DCGO - GBCS
2%
Poorly correlated
+4.64%
BDULF - GBCS
1%
Poorly correlated
N/A
More